Appeal No. 95-4791
Application 08/034,849
This is an appeal under 35 U.S.C. § 134 of an examiner’s
rejection of Claims 1-13, all claims pending in this
application. Claims 1-13 stand finally rejected under 35
U.S.C. § 103 as being unpatentable in view of the combined
teachings of Sanosa G.M.B.H. (Sanosa), UK Patent Specification
481,732, published March 16, 1938; The Merck Index, 10th
Edition, page 1236, Abstract No. 8465 (1983); Kuhne et al.
(Kuhne I), EP-200,156, published November 5, 1986; Kuhne et2
al. (Kuhne II), EP-200,157, published November 5, 1986; and3
the prior art described in appellant’s specification. The
examiner has withdrawn the final rejection of Claims 1-13
under 35 U.S.C. § 101 (Examiner’s Answer (Ans.), page 2).
Claims 1, 10 and 11 are representative of the subject matter
claimed and read:
1. A method of parenterally treating HIV
infections, comprising administering to a subject in
need of such treatment an inhibition-effective amount of
a chemically-stabilized chlorite matrix comprising an
isotonic solution containing about 5 to about 100 mMol
ClO per liter of isotonic solution.2-
10. A method according to claim 1, wherein the
2 Canadian Patent 1,268,714, issued May 8, 1990,
appears to be the English equivalent.
3 Australian Patent Specification 599,027, published
November 6, 1986, appears to be the English equivalent.
2
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007